Free Trial
→ “Buffett Indicator” Predicts 62% Stock Market Crash (From Behind the Markets) (Ad)

15 Healthcare Stocks that Analysts Love in a Post-Pandemic World - 7 of 15

Slide 7
Back to 6
Continue to 8
 
Back to 6
Continue to 8
 

GSK (NYSE:GSK)

Consensus Rating
Moderate Buy
Rating Score
2.9
Ratings Breakdown
5 Buy Ratings, 4 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$50.00 (22.3% Upside)

About GSK

GSK logoGSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
8/27/2024BarclaysUpgradeHold
8/7/2024ArgusUpgradeStrong-Buy
7/8/2024UBS GroupDowngradeBuy ➝ Neutral
7/2/2024Jefferies Financial GroupBoost Price TargetBuy ➝ Buy$52.50 ➝ $53.00
6/24/2024CitigroupUpgradeStrong-Buy
6/20/2024Berenberg BankUpgradeStrong-Buy
5/30/2024The Goldman Sachs GroupInitiated CoverageNeutral$47.00
3/4/2024GuggenheimUpgradeNeutral ➝ Buy
2/13/2024CitigroupUpgradeNeutral ➝ Buy
1/23/2024Morgan StanleyInitiated CoverageEqual Weight
Slide 7
Back to 6
Continue to 8
 

Our #1 Ticker for the Rare "Retirement Window" (Ad)

We've only seen this happen three times in the past 20 years... And every time - like clockwork - it's minted an entire new class of millionaires.

Click here for our #1 "Retirement Window" Stock >>>

More From MarketBeat
Shocking prediction from firm that predicted President Kamala
Prepare for President Kamala I won't be voting for her. Even so, I'm worried VP Kamala Harris could pull of...
Stansberry Research | Sponsored
7 Russell 2000 Stocks to Buy as Sector Rotation Begins
The myth of the Russell 2000 index is that it's a small-cap index. In reality, the index focuses on both small...
MarketBeat
Tim Sykes’ Urgent Trade Alert: “Make this move now”
WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...
Timothy Sykes | Sponsored
7 Dividend Aristocrats to Buy After Earnings
During earnings season, analysts talk about earnings growth — and for good reason. Nothing drives stock ...
MarketBeat
Unlock the Secret to Easy Wins with Iron Condors
Discover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...
Netpicks | Sponsored
7 Energy Stocks with Attractive High-Yield Dividends
With interest rates likely to move lower starting with the Federal Reserve's September meeting, many investors...
MarketBeat